{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:02:02Z","timestamp":1793898122945,"version":"4.8.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jhep.2022.09.020","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T22:33:12Z","timestamp":1665095592000},"page":"415-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":453,"title":["Mitochondrial alterations in fatty liver diseases"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-5465","authenticated-orcid":false,"given":"Bernard","family":"Fromenty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8200-6382","authenticated-orcid":false,"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10319","key":"10.1016\/j.jhep.2022.09.020_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2022.09.020_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00015.2017","article-title":"Interorgan metabolic crosstalk in human insulin resistance","volume":"98","author":"Gancheva","year":"2018","journal-title":"Physiol Rev"},{"issue":"7785","key":"10.1016\/j.jhep.2022.09.020_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.09.020_bib6","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.09.020_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.livres.2019.06.001","article-title":"Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis","volume":"3","author":"Fromenty","year":"2019","journal-title":"Liver Res"},{"key":"10.1016\/j.jhep.2022.09.020_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110916","article-title":"Alteration of mitochondrial DNA homeostasis in drug-induced liver injury","volume":"135","author":"Fromenty","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jhep.2022.09.020_bib9","first-page":"75","article-title":"Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives","volume":"4","author":"Ramachandran","year":"2018","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.jhep.2022.09.020_bib10","article-title":"Metabolic liver disease in diabetes \u2013 from mechanisms to clinical trials","volume":"111S","author":"Dewidar","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2022.09.020_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhep.2022.09.020_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/biomedicines8110526","article-title":"Mitochondria at work: new insights into regulation and dysregulation of cellular energy supply and metabolism","volume":"8","author":"Schirrmacher","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhep.2022.09.020_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jhep.2022.09.020_bib14","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.3390\/ijms21155266","article-title":"Roles of mitochondrial sirtuins in mitochondrial function, redox homeostasis, insulin resistance and type 2 diabetes","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2022.09.020_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/febs.13820","article-title":"Mitochondrial biogenesis and clearance: a balancing act","volume":"284","author":"Ploumi","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.jhep.2022.09.020_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.redox.2014.11.006","article-title":"Mitochondrial dynamics and mitochondrial quality control","volume":"4","author":"Ni","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhep.2022.09.020_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41418-020-00657-z","article-title":"Functions of outer mitochondrial membrane proteins: mediating the crosstalk between mitochondrial dynamics and mitophagy","volume":"28","author":"Xian","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhep.2022.09.020_bib18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jhep.2021.01.028","article-title":"STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway","volume":"74","author":"Conde de la Rosa","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.redox.2015.02.003","article-title":"H2O2 release from the very long chain acyl-CoA dehydrogenase","volume":"4","author":"Kakimoto","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhep.2022.09.020_bib20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/antiox9100980","article-title":"Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects","volume":"9","author":"Galicia-Moreno","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jhep.2022.09.020_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fcell.2018.00031","article-title":"Sensing the stress: a role for the UPRmt and UPRam in the quality control of mitochondria","volume":"6","author":"Callegari","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jhep.2022.09.020_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/cells11020288","article-title":"Role of mitochondrial cytochrome P450 2E1 in healthy and diseased liver","volume":"11","author":"Massart","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2022.09.020_bib23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/ijms23031062","article-title":"Xenobiotic-induced aggravation of metabolic-associated fatty liver disease","volume":"23","author":"Massart","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2022.09.020_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib25","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.2337\/db11-0338","article-title":"Oxidative phosphorylation flexibility in the liver of mice resistant to high-fat diet-induced hepatic steatosis","volume":"60","author":"Poussin","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2022.09.020_bib26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI89444","article-title":"Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance","volume":"127","author":"Hern\u00e1ndez","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2022.09.020_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-nutr-071715-050656","article-title":"Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus","volume":"36","author":"Koliaki","year":"2016","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jhep.2022.09.020_bib28","doi-asserted-by":"crossref","first-page":"bnaa004","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically healthy obesity","volume":"41","author":"Bl\u00fcher","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jhep.2022.09.020_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jhep.2022.09.020_bib30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.23093","article-title":"Abnormal hepatic energy homeostasis in type 2 diabetes","volume":"50","author":"Szendroedi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.09.020_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/dc10-1076","article-title":"Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes","volume":"34","author":"Schmid","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2022.09.020_bib32","first-page":"24167","article-title":"Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy","author":"Petersen","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib34","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.1038\/ncomms9994","article-title":"Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease","volume":"7","author":"Hy\u00f6tyl\u00e4inen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.09.020_bib35","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2022.09.020_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127737","article-title":"Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver","volume":"4","author":"Fletcher","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhep.2022.09.020_bib37","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/s41467-022-30629-5","article-title":"Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration","volume":"13","author":"Pedersen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.09.020_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","author":"Moore","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.09.020_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jhep.2020.11.030","article-title":"Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus","volume":"74","author":"Kupriyanova","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib41","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/aacf12","article-title":"The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the (13)C-ketoisocaproate breath test","volume":"12","author":"Afolabi","year":"2018","journal-title":"J Breath Res"},{"key":"10.1016\/j.jhep.2022.09.020_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00125-006-0489-8","article-title":"Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes","volume":"50","author":"Misu","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2022.09.020_bib43","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1113\/JP272105","article-title":"Hepatic mitochondrial oxidative phosphorylation is normal in obese patients with and without type 2 diabetes","volume":"594","author":"Lund","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.jhep.2022.09.020_bib44","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/dc20-0329","article-title":"Role of patatin-like phospholipase domain-containing 3 gene for hepatic lipid content and insulin resistance in diabetes","volume":"43","author":"Zaharia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2022.09.020_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12881-016-0324-0","article-title":"The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)","volume":"17","author":"Mehta","year":"2016","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jhep.2022.09.020_bib46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jcmgh.2021.11.007","article-title":"TM6SF2\/PNPLA3\/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models","volume":"13","author":"Longo","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib47","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.metabol.2015.09.002","article-title":"Insulin resistance in type 1 diabetes mellitus","volume":"64","author":"Kaul","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2022.09.020_bib48","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.09.020_bib49","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1038\/s41598-021-82884-z","article-title":"Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease","volume":"11","author":"Shami","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.09.020_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2022.09.020_bib51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/egh.11.11","article-title":"Mitochondrial dysfunction in nonalcoholic steatohepatitis","volume":"5","author":"Serviddio","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib52","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","article-title":"Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study","volume":"282","author":"Cortez-Pinto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2022.09.020_bib53","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"P\u00e9rez-Carreras","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.09.020_bib54","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.09.020_bib55","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","article-title":"Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion","volume":"274","author":"Chavin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2022.09.020_bib56","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2741\/1683","article-title":"Uncoupling protein-2 and non-alcoholic fatty liver disease","volume":"10","author":"Baffy","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.jhep.2022.09.020_bib57","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00407.2007","article-title":"Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet","volume":"294","author":"Romestaing","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib58","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/ars.2010.3795","article-title":"Mitochondria and redox signaling in steatohepatitis","volume":"15","author":"Morris","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jhep.2022.09.020_bib59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jcmgh.2020.09.004","article-title":"Liver pyruvate kinase promotes NAFLD\/NASH in both mice and humans in a sex-specific manner","volume":"11","author":"Chella Krishnan","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib60","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1572-0241.2003.07725.x","article-title":"Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test","volume":"98","author":"Miele","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2022.09.020_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024084","article-title":"Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet","volume":"6","author":"Serviddio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2022.09.020_bib62","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jnutbio.2014.06.010","article-title":"Postnatal overfeeding promotes early onset and exaggeration of high-fat diet-induced nonalcoholic fatty liver disease through disordered hepatic lipid metabolism in rats","volume":"25","author":"Ji","year":"2014","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jhep.2022.09.020_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108505","article-title":"Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice","volume":"87","author":"Zamani-Garmsiri","year":"2021","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jhep.2022.09.020_bib64","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","article-title":"Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects","volume":"142","author":"Magkos","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.09.020_bib65","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.cmet.2020.08.001","article-title":"A membrane-bound diacylglycerol species induces PKC\u03f5-mediated hepatic insulin resistance","volume":"32","author":"Lyu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib66","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2022.09.020_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001860","article-title":"Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans","volume":"8","author":"Apostolopoulou","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jhep.2022.09.020_bib68","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib69","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2337\/dc21-1758","article-title":"Impaired hepatic mitochondrial capacity in nonalcoholic steatohepatitis associated with type 2 diabetes","volume":"45","author":"Gancheva","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2022.09.020_bib70","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00394-012-0356-y","article-title":"Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose","volume":"52","author":"Crescenzo","year":"2013","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jhep.2022.09.020_bib71","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2013.11.020","article-title":"Liver adapts mitochondrial function to insulin resistant and diabetic states in mice","volume":"60","author":"Franko","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib72","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2337\/db16-1147","article-title":"Mechanisms of insulin resistance in primary and secondary nonalcoholic fatty liver","volume":"66","author":"Jelenik","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2022.09.020_bib73","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.09.020_bib74","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.freeradbiomed.2009.06.015","article-title":"Curcumin ameliorates rabbits\u2019s steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha","volume":"47","author":"Ramirez-Tortosa","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2022.09.020_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108888","article-title":"Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction","volume":"100","author":"Li","year":"2022","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jhep.2022.09.020_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.743892","article-title":"Molecular machinery and pathophysiology of mitochondrial dynamics","volume":"9","author":"Chiu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jhep.2022.09.020_bib77","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/bs.mcb.2019.11.010","article-title":"In vitro and in vivo assays for mitochondrial fission and fusion","volume":"155","author":"Hoppins","year":"2020","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.jhep.2022.09.020_bib78","doi-asserted-by":"crossref","first-page":"31484","DOI":"10.1074\/jbc.M109.033936","article-title":"Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia inhibition of FoxO1-dependent expression of key autophagy genes by insulin","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2022.09.020_bib79","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00169.2012","article-title":"PGC-1\u03b1 overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion","volume":"303","author":"Morris","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2022.09.020_bib80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2018.06.014","article-title":"Mitochondrial stasis reveals p62-mediated ubiquitination in Parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease","volume":"28","author":"Yamada","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib81","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00125-021-05488-2","article-title":"Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor","volume":"64","author":"Takeichi","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2022.09.020_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154708","article-title":"Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?","volume":"117","author":"Longo","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2022.09.020_bib83","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5604\/16652681.1171749","article-title":"Drug-induced fatty liver disease: an overview of pathogenesis and management","volume":"14","author":"Satapathy","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib84","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1039\/c7tx00326a","article-title":"Role of xenobiotics in the induction and progression of fatty liver disease","volume":"7","author":"Klaunig","year":"2018","journal-title":"Toxicol Res (Camb)"},{"key":"10.1016\/j.jhep.2022.09.020_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10565-020-09537-1","article-title":"Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity","volume":"37","author":"Allard","year":"2021","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.jhep.2022.09.020_bib86","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.3390\/ijms22094807","article-title":"Role of endocrine-disrupting chemicals in the pathogenesis of non-alcoholic fatty liver disease: a comprehensive review","volume":"22","author":"Cano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2022.09.020_bib87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhep.2022.09.020_bib88","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2022.09.020_bib89","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/0960327112444477","article-title":"Involvement of fatty acid metabolism in the hepatotoxicity induced by divalproex sodium","volume":"31","author":"Wang","year":"2012","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.jhep.2022.09.020_bib90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2007.06.003","article-title":"Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration","volume":"223","author":"Nadanaciva","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2022.09.020_bib91","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/gast.2002.35952","article-title":"Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice","volume":"123","author":"Demeilliers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.09.020_bib92","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41419-021-03980-6","article-title":"Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPAR\u03b1 pathway","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhep.2022.09.020_bib93","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-022-28201-2","article-title":"Depletion of mitochondrial methionine adenosyltransferase \u03b11 triggers mitochondrial dysfunction in alcohol-associated liver disease","volume":"13","author":"Barbier-Torres","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.09.020_bib94","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.510300434","article-title":"Chronic ethanol consumption causes alterations in the structural integrity of mitochondrial DNA in aged rats","volume":"30","author":"Cahill","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.09.020_bib95","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1136\/gutjnl-2020-321548","article-title":"ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis","volume":"70","author":"Hao","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.09.020_bib96","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1194\/jlr.M200200-JLR200","article-title":"Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate","volume":"44","author":"Spaniol","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2022.09.020_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.taap.2018.11.007","article-title":"Clozapine-induced reduction of l-carnitine reabsorption via inhibition\/down-regulation of renal carnitine\/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice","volume":"363","author":"Wang","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2022.09.020_bib98","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0192623312468517","article-title":"Toxicant-associated steatohepatitis","volume":"41","author":"Wahlang","year":"2013","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jhep.2022.09.020_bib99","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2015.08.022","article-title":"Mechanistic review of drug-induced steatohepatitis","volume":"289","author":"Schumacher","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2022.09.020_bib100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2011.07.019","article-title":"Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis","volume":"256","author":"Lu","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2022.09.020_bib101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2022.09.020_bib102","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0016-5085(98)70590-6","article-title":"Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes","volume":"114","author":"Berson","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.09.020_bib103","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib104","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.freeradbiomed.2011.09.004","article-title":"Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration","volume":"51","author":"Serviddio","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2022.09.020_bib105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/jpet.114.219832","article-title":"Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model","volume":"352","author":"Zhang","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2022.09.020_bib106","article-title":"Acute liver failure in a military recruit treated with valproic acid and harboring a previously unrecognized POLG-1 mutation","volume":"12","author":"Bassett","year":"2019","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.jhep.2022.09.020_bib107","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1053\/gast.2001.24051","article-title":"Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease","volume":"120","author":"Degoul","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.09.020_bib108","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-019-0094-1","article-title":"DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy","volume":"4","author":"Zhou","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhep.2022.09.020_bib109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/19768354.2021.1882565","article-title":"Rutin inhibits DRP1-mediated mitochondrial fission and prevents ethanol-induced hepatotoxicity in HepG2 cells and zebrafish","volume":"25","author":"Choi","year":"2021","journal-title":"Anim Cells Syst (Seoul)"},{"key":"10.1016\/j.jhep.2022.09.020_bib110","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1111\/jcmm.14388","article-title":"HBx combined with AFB1 triggers hepatic steatosis via COX-2-mediated necrosome formation and mitochondrial dynamics disorder","volume":"23","author":"Chen","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jhep.2022.09.020_bib111","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/livers1030010","article-title":"Mitochondrial dynamics in drug-induced liver injury","volume":"1","author":"Ramachandran","year":"2021","journal-title":"Livers"},{"key":"10.1016\/j.jhep.2022.09.020_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110258","article-title":"Fatal acetaminophen poisoning with hepatic microvesicular steatosis in a child after repeated administration of therapeutic doses","volume":"310","author":"Bouvet","year":"2020","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jhep.2022.09.020_bib113","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jhep.2021.01.045","article-title":"Diagnosis and management of secondary causes of steatohepatitis","volume":"74","author":"Liebe","year":"2021","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2022.09.020_bib114","first-page":"212","article-title":"Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity","volume":"3","author":"Massart","year":"2017","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.jhep.2022.09.020_bib115","doi-asserted-by":"crossref","first-page":"rkaa020","DOI":"10.1093\/rap\/rkaa020","article-title":"Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study","volume":"4","author":"Mori","year":"2020","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.jhep.2022.09.020_bib116","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.14434","article-title":"Prevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"40","author":"Lee","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2022.09.020_bib117","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0040-1701443","article-title":"Drinking and obesity: alcoholic liver disease\/nonalcoholic fatty liver disease interactions","volume":"40","author":"\u00c5berg","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2022.09.020_bib118","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2010.12.034","article-title":"Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK","volume":"55","author":"Xu","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib119","doi-asserted-by":"crossref","first-page":"G38","DOI":"10.1152\/ajpgi.00309.2012","article-title":"Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice","volume":"304","author":"Everitt","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2022.09.020_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.taap.2015.02.021","article-title":"Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis","volume":"284","author":"Strakovsky","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2022.09.020_bib121","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03602532.2011.604086","article-title":"Central role of mitochondria in drug-induced liver injury","volume":"44","author":"Pessayre","year":"2012","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhep.2022.09.020_bib122","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ame2.12042","article-title":"Obese zebrafish: a small fish for a major human health condition","volume":"1","author":"Faillaci","year":"2018","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.jhep.2022.09.020_bib123","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jat.4031","article-title":"Zebrafish: an emerging model system to study liver diseases and related drug discovery","volume":"41","author":"Katoch","year":"2021","journal-title":"J Appl Toxicol"},{"issue":"8","key":"10.1016\/j.jhep.2022.09.020_bib124","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1038\/s41598-018-24403-1","article-title":"Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo","volume":"13","author":"Bucher","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.09.020_bib125","article-title":"Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene\/ethanol co-exposure","author":"Imran","year":"2022","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.jhep.2022.09.020_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4396403","article-title":"Possible involvement of mitochondrial dysfunction and oxidative stress in a cellular model of NAFLD progression induced by benzo[a]pyrene\/ethanol coexposure","author":"Bucher","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jhep.2022.09.020_bib127","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134520","article-title":"Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance","volume":"5","author":"Sarabhai","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhep.2022.09.020_bib128","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1073\/pnas.1922344117","article-title":"Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease","volume":"117","author":"Luukkonen","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2022.09.020_bib129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2014-306748","article-title":"Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis","volume":"64","author":"Verbeek","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.09.020_bib130","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13600","article-title":"Effect of Roux-en-Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity","volume":"6","author":"Sacks","year":"2018","journal-title":"Physiol Rep"},{"key":"10.1016\/j.jhep.2022.09.020_bib131","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1038\/s41467-019-12081-0","article-title":"Dynamic changes of muscle insulin sensitivity after metabolic surgery","volume":"10","author":"Gancheva","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.09.020_bib132","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tem.2019.07.013","article-title":"Are lifestyle therapies effective for NAFLD treatment?","volume":"30","author":"El-Agroudy","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.11.015","article-title":"Physical exercise and liver \u201cfitness\u201d: role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease","volume":"32","author":"Stevanovi\u0107","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib134","doi-asserted-by":"crossref","first-page":"E165","DOI":"10.1152\/ajpendo.00266.2017","article-title":"Exercise training reduces intrahepatic lipid content in people with and people without nonalcoholic fatty liver","volume":"314","author":"Brouwers","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154892","article-title":"Insulin resistance and insulin sensitizing agents","volume":"125","author":"Mastrototaro","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2022.09.020_bib136","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jhep.2022.09.020_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106114","article-title":"Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications","volume":"177","author":"Feng","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jhep.2022.09.020_bib138","article-title":"Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: a phase 1b study","volume":"2","author":"Fouqueray","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jhep.2022.09.020_bib139","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1089\/thy.2020.0071","article-title":"Thyroid hormone analogues: an update","volume":"30","author":"Zucchi","year":"2020","journal-title":"Thyroid"},{"issue":"10213","key":"10.1016\/j.jhep.2022.09.020_bib140","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2022.09.020_bib141","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13181-011-0162-6","article-title":"2,4-Dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death","volume":"7","author":"Grundlingh","year":"2011","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.jhep.2022.09.020_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101178","article-title":"Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH","volume":"46","author":"Goedeke","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib143","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42255-020-0209-6","article-title":"Resolution of NASH and hepatic fibrosis by the GLP-1R\/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis","volume":"2","author":"Boland","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2022.09.020_bib144","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/j.cgh.2018.12.013","article-title":"Patients with chronic liver disease suggestive of nonalcoholic fatty liver disease may be at higher risk for drug-induced liver injury","volume":"17","author":"Lammert","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib145","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/apt.15153","article-title":"Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis","volume":"49","author":"Regev","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2022.09.020_bib146","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.apsb.2021.05.028","article-title":"Hepatotoxicity reports in the FDA adverse event reporting system database: a comparison of drugs that cause injury via mitochondrial or other mechanisms","volume":"11","author":"Rana","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jhep.2022.09.020_bib147","doi-asserted-by":"crossref","first-page":"C1248","DOI":"10.1152\/ajpcell.00035.2022","article-title":"The role of mitochondria in the pathophysiology and treatment of common metabolic diseases","volume":"322","author":"Georgiev","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jhep.2022.09.020_bib148","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jhep.2020.07.014","article-title":"Extracellular vesicles as biomarkers in liver diseases: a clinician\u2019s point of view","volume":"73","author":"Thietart","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2022.09.020_bib149","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1096\/fj.201901917RR","article-title":"Blood contains circulating cell-free respiratory competent mitochondria","volume":"34","author":"Al Amir Dache","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2022.09.020_bib150","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","article-title":"Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation","volume":"11","author":"Barbier-Torres","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.09.020_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103996","article-title":"Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver","volume":"25","author":"Yamada","year":"2022","journal-title":"iScience"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822031300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822031300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:48:28Z","timestamp":1759175308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822031300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":151,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0168827822031300"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.09.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial alterations in fatty liver diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}